Cloud-clone
SKU:RPJ226Ra02
Recombinant Biglycan (BGN)
Recombinant Biglycan (BGN)
Couldn't load pickup availability
Prokaryotic expression
Product No.
RPJ226Ra02
Organism Species
Rattus norvegicus (Rat).
Source
Prokaryotic expression
Host
E.coli
Endotoxin Level
<1.0EU per 1µg (determined by the LAL method)
Subcellular Location
Secreted, Extracellular matrix
Predicted Molecular Mass
15.8kDa
Accurate Molecular Mass
17kDa(Analysis of differences refer to the manual)
Residues & Tags
Gln243~Lys369 with N-terminal His Tag
Buffer Formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Traits
Freeze-dried powder
Purity
> 90%
Isoelectric Point
9.2
Applications
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
UOM
10µg 50µg 200µg 1mg 5mg
SEQUENCE
USAGE
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Sci Rep. | Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysreCavia (Guinea pig )lation of biglycan Pubmed:27295191 |
| Cell Death & Disease | Tenomodulin is essential for prevention of adipocyte accumulation and fibrovascular scar formation during early tendon healing. pubmed:29022912 |
| Diabetes & Vascular Disease Research | Degenerative aortic valve disease and diabetes: Implications for a link between proteoglycans and diabetic disorders in the aortic valve Pubmed: 30563371 |
| 博士论文 | Die Rolle der extrazellulären Matrix in der degenerativen Aortenklappenerkrankung unter dem Einfluss von Diabetes |
| J Transl Med | Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans 33407555 |
| researchsquare | Inhibition of Stromal Biglycan Promotes Normalization of the Tumor Microenvironment and Enhances Chemotherapeutic Efficacy 33966638 |
| Catalog No. | Related products for research use of Rattus norvegicus (Rat) Organism species | Applications (RESEARCH USE ONLY!) |
| RPJ226Ra01 | Recombinant Biglycan (BGN) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPJ226Ra02 | Recombinant Biglycan (BGN) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAJ226Ra02 | Polyclonal Antibody to Biglycan (BGN) | WB; IHC; ICC; IP. |
| PAJ226Ra01 | Polyclonal Antibody to Biglycan (BGN) | WB; IHC; ICC; IP. |
| LAJ226Ra71 | Biotin-Linked Polyclonal Antibody to Biglycan (BGN) | WB; IHC; ICC. |
| MAJ226Ra21 | Monoclonal Antibody to Biglycan (BGN) | WB; IHC; ICC; IP. |
| SEJ226Ra | ELISA Kit for Biglycan (BGN) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMJ226Ra | Magnetic Luminex Assay Kit for Biglycan (BGN) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
